Victor Stams, MD
Plastic and Reconstructive Surgery · Champaign, ILNPI 1710148739
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,600 of the $4,356 with a category attached, or 82.7%. Novartis accounts for 82.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $3,639 and has fallen 96.9% since, to $111 in 2025.
Across 29 payments — averaging $150.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$4K
- Mentor Worldwide LLC$317
- KCI USA, Inc.$126
- Musculoskeletal Transplant Foundation Inc.$85
- Johnson & Johnson$71
- AbbVie$51
- plus $104 from 5 others
What the payments were for
- Consulting fees$3,60083%
- Food & beverage$75617%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 2 | $3,600 |
| Mentor Worldwide LLC | 12 | $317 |
| KCI USA, Inc. | 2 | $126 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $85 |
| Johnson & Johnson | 3 | $71 |
| AbbVie | 3 | $51 |
| Motiva USA, LLC | 1 | $31 |
| Misonix Inc | 1 | $24 |
| Merck | 1 | $20 |
| Smith+Nephew | 1 | $16 |
| Sientra, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COSENTYX$1,200
- VAC VERAFLO$105
How this compares
$4,356 in reported general payments places this provider in the 65th percentile of 126 plastic and reconstructive surgery providers in Illinois.
See all plastic and reconstructive surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 12 | $226 |
| Cephalexin | 25 | $160 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $134 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $43 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Champaign
- Ronald RussoChampaign$9K
- John KimChicago$7.3M
- Mark SiscoNorthbrook$309K
- Steven SigaloveGlen Ellyn$218K
- Matthew EndaraJoliet$204K
- Brian MaileySpringfield$182K
- Julius FewChicago$148K
- Eleanor BucholzMaywood$63K
- Gregory DumanianChicago$50K
- Daniel LiuZion$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.